000			01731 a2200505 4500
005			20250516052050.0
264		0	_c20120224
008			201202s 0 0 eng d
022			_a1543-8392
024	7		_a10.1021/mp200133s _2doi
040			_aNLM _beng _cNLM
100	1		_aChang, Li-Chien
245	0	0	_aSustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy. _h[electronic resource]
260			_bMolecular pharmaceutics _cOct 2011
300			_a1767-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBleeding Time
650	0	4	_aDelayed-Action Preparations _xadministration & dosage
650	0	4	_aDrug Compounding
650	0	4	_aEmulsions
650	0	4	_aEnzyme Stability
650	0	4	_aFactor IX _xadministration & dosage
650	0	4	_aHemophilia B _xblood
650	0	4	_aInjections, Subcutaneous
650	0	4	_aLactic Acid _xchemistry
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMicroscopy, Electron, Scanning
650	0	4	_aMicrospheres
650	0	4	_aPartial Thromboplastin Time
650	0	4	_aParticle Size
650	0	4	_aPolyglycolic Acid _xchemistry
650	0	4	_aPolylactic Acid-Polyglycolic Acid Copolymer
650	0	4	_aRandom Allocation
650	0	4	_aRecombinant Proteins _xadministration & dosage
650	0	4	_aSolubility
650	0	4	_aSurface Properties
700	1		_aYang, Chi-Yu
700	1		_aChua, Anna Chian New
700	1		_aLin, Yi-Juain
700	1		_aLai, Sun-Mou
773	0		_tMolecular pharmaceutics _gvol. 8 _gno. 5 _gp. 1767-74
856	4	0	_uhttps://doi.org/10.1021/mp200133s _zAvailable from publisher's website
999			_c21086870 _d21086870